Interventional cardiology news to note
Cardiovascular trials used to support current guidelines on myocardial revascularization have a robustness problem: over a quarter of these studies would have had statistically significant results rendered nonsignificant if just three patients without events did have events after all. This number, known as the frailty index, was lower than the number of people lost to follow-up in more than 40% of trials, according to a report in Circulation: Cardiovascular Quality and Outcomes.